This past July Stryker
Orthopedics recalled two hip implant models: the Rejuvenate and the ABGII. The
Rejuvenate gained FDA approval only a few short years earlier, in 2008. The
approval for the Rejuvenate fell under a process known as the 510(k) which has
come under fire after many devices approved under the process were found to be
defective. Under this process a new medical device must only show it is
substantially equivalent to a device which has already garnered FDA approval.
Clinical trials are not a requirement of the 510(k), therefore many people have
ended up harmed from a defective medical device approved under this process.
In fact, the Rejuvenate
received FDA approval based on its similarity to the Wright Profemur modular
neck device. The Pro-femur has not been recalled, however since its
introduction to the market in 2000, there have been a significant number of adverse
reports regarding the device as well as injury lawsuits filed against the
company. Many of these lawsuits allege that Wright was aware of the problems
associated with the Pro-femur including an unusually high risk of failure and
fracture. Like the Rejuvenate, the Pro-femur also has a significant risk of
fretting and corrosion.
Is the Stryker Rejuvenate Defective Because of the Dual Modularity?
Originally all hip implants
were designed with one junction between the ball and the neck portion. Dual modularity
implemented a junction between the ball and the neck as well as a junction
between the neck and the stem. Stryker’s goal with the new dual modularity
design was to allow surgeons to use multiple necks with various angles and
lengths so a custom fit for each individual patient could be obtained.
The surgeon can choose the
size and length of the ball, the length of the stem section, the shape and size
of the upper end of the femoral component and the degree of rotation and
offset. While in theory the dual modularity hip implant device should provide a
huge gain in performance as well as putting an end to safety issues which
occurred from a poor fit. But dual modularity design also increases the
likelihood of separation between the body and the neck, thus increasing the
levels of metal ion debris.
When Dual Modularity Causes Corrosion
There are three types of
corrosion the Rejuvenate is subject to: crevice corrosion, fretting corrosion
and galvanic corrosion. When a dual modularity device such as the Stryker
Rejuvenate is used, a good taper must be implemented at the modularity points.
Many hip implant manufacturers use a Morse taper however due to a variety of
manufacturers, the tapers are not uniform in their dimensions. Even the
slightest variance can greatly increase the risk of dislocation for the
patient.
The Morse taper may also
connect two disparate materials which can also increase the risks of fretting
and corrosion. When a ceramic femoral head is used, the Morse tapers which join
the head with the shaft can produce stress within the ceramic material. These
are known as hoop stresses and can lead to serious fractures of the ceramic
head when products of two different manufacturers are placed together. As you can see, the dual modularity of the
Stryker Rejuvenate could well be reason for the recall.
No comments:
Post a Comment